Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …

It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein, including …

In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

COVID-19 mRNA vaccines are highly efficacious in preventing COVID-19 morbidity and
mortality in phase 3 clinical studies as well as in real-world settings. Emerging evidence …

Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been developed. However, the emergence of viral variants that are more …

It is thought that mRNA-based vaccine-induced immunity to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) wanes quickly, based mostly on short-term studies. Here, …

The PARIS (Protection Associated with Rapid Immunity to SARS-CoV-2) cohort follows health
care workers with and without documented coronavirus disease 2019 (COVID-19) since …

Graphite is found dispersed in high-grade metapelitic rocks of the Anatectic Complex of
Toledo (ACT) and was mined during the mid twentieth century in places where it has been …

Serological tests are important tools helping to determine previous infection with severe acute
respiratory disease coronavirus 2 (SARS-CoV-2) and to monitor immune responses. The …

To understand reinfection rates and correlates of protection for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), we established eight different longitudinal cohorts in …